Salute e Benessere

Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab…

Vironova BioAnalytics has established a strong reputation as a trusted partner for pharmaceutical companies globally, known for its commitment to high-quality standards. This acquisition represents an important step in the company's growth journey, fostering opportunities for innovation and expansion. The strategic decision to rebrand the company as QuTEM reflects the commitment to evolving and delivering cutting-edge TEM solutions to meet the evolving quality control needs of the...

Soaring Hypertension Rates Drive Blood Pressure Monitor Market to US$4.07…

NEWARK, Del., Nov. 20, 2023 /PRNewswire/ -- As per the latest analysis, the global blood pressure monitor market value is projected to surge from US$ 2.26 billion in 2024 to US$ 4.07 billion in 2034. Over the forecast period, sales of blood pressure monitors will likely rise at a CAGR of 6.1%. NEWARK, Del.,Nov. 20, 2023/PRNewswire/ -- As per the latest analysis, the global blood pressure monitor market value is projected to surge from US$ 2.26 billion in 2024 to US$ 4.07 billion ...

Photocure to present at four investor conferences in November/December 2023

The 35th Annual Piper Sandler Healthcare Conference will be held in New York City, November 28-30, 2023. Dan Schneider, Photocure's President and CEO will present on November 28 at 9:50am ET. A webcast of the presentation will be available at: Photocure ASA (PHO NO) - 1644046 (webcasts.com) The 35 th Annual Piper Sandler Healthcare Conference will be held inNew York City,November 28-30, 2023.Dan Schneider, Photocure's President and CEO will present onNovember 28at9:50am ET...

Smart Health, a collaboration of Visiomed, Abrar Communications, and Al…

This highlight of the exhibition marks both the significant confidence in the in-depth work carried out with the Ministry of Health over the last few months, and the willingness of Smart Health and the Government to accelerate their collaboration with a common objective: to define a large-scale project and a roadmap for the deployment of a network of medical diagnostic services across the Kingdom in order to meet the many demographic and health challenges driving Saudi Arabia and its…

Update on the receivership proceedings: submission of a takeover offer to the…

Update on the receivership proceedings: submission of a takeover offer to the court-appointed administratorsParis, France, November 20, 2023 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, whose safeguard proceedings ( procédure de sauvegarde ) were converted into receivership ( redressement judiciaire ) by...

ELISpot and FluoroSpot Assay Market worth $421 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584 Browse in-depth TOC on "ELISpot and FluoroSpot Assay Market" 207 - Tables 47 - Figures 232 - Pages ELISpot and FluoroSpot Assay Market Scope: EliSpot Assay kits in the kits product segment to witness the highest shares during the forecast period. Based on the...

Clinical Trials Market Size Estimated to Surpass USD 83.55 Billion by 2032 |…

Clinical Trials are research studies that test the safety and efficacy of new medical, surgical, or behavioral interventions in humans. These trials are the primary way researchers determine if a new treatment or prevention is safe and effective in humans. Clinical trials are research studies in which participants are assigned at random to one or more interventions to see what happens in individuals. As a result, clinical trials are also known as interventional studies. Sometimes, the…

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 20 November 2023– On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under…

Information about Essity's ownership in Vinda

Essity's ownership in Vinda amounts to 51.59%. Vinda is listed on the Hong Kong stock exchange. Essity's ownership in Vinda amounts to 51.59%. Vinda is listed on theHong Kongstock exchange. Vinda's announcement may be found here:http://www.vinda.com/upload/files/20231120/22240222hf.pdf Essity will not make any further comments. NB:This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information...

BBS-Bioactive Bone Substitutes Plc: BBS arranges a rights offering of…

BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider information, 20 November 2023 at 17.03 p.m. EEST BBS arranges a rights offering of approximately maximum EUR 2.63 million NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL.BBS arranges a rights offering of approximately maximum EUR 2...

SURREY FA UNITE LOCAL COMMUNITIES AND ASYLUM SEEKERS THROUGH FOOTBALL

In September 2022, Surrey FA launched Unite Through Football: Refugees, in collaboration with leading accommodation provider SBHL and Surrey Police to support those living in these circumstances. The ground-breaking programme provided a much-needed opportunity for young men and women across the South East to play football and connect with local communities while positively supporting their mental health and wellbeing.After a successful first year, Surrey FA's Unite Through Football: Refugees…

Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation…

The company's skin-tightening device features a high-intensity parallel beam ultrasound to treat skin laxity without injuring the epidermis. Sofwave's technology is completely non-invasive and causes no discomfort to the patient, which makes it an effective and convenient technology for patients who expect excellent results in a short time. The company's skin-tightening device features a high-intensity parallel beam ultrasound to treat skin laxity without injuring the epidermis. Sofwave's...

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics…

Life science research studies are frequently constrained by their inability to easily and efficiently secure adequate, stable biological samples. Mitra devices offer precision via a volumetric absorptive microsampling method that is minimally invasive and user-friendly. This microsampling technique is ideal when working in a preclinical research lab setting. Smaller microliter sample volumes also enable research not possible with standard blood collection techniques, such as sample collection at…

SURREY FA UNITE LOCAL COMMUNITIES AND ASYLUM SEEKERS THROUGH FOOTBALL

Speaking on the day, Surrey FA Chief Executive Officer, Sally Lockyer, said:"We have seen a growing population of refugees within the South East, and we want to create opportunities for them to play football, boost their mental health, and connect with the local community. Following a successful first season, we're delighted that with the sponsorship support of SBHL, we can continue to create opportunities for our refugee community to participate in sporting activities. Not only does it…

Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)

ORION CORPORATIONPRESS RELEASE20 NOVEMBER 2023 at 15.00 EET Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution) Orion Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Bonqat® (pregabalin oral solution)for alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.Pregabalin is a new active substance for veterinary use and it acts in the...

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma…

Calyx CTMS Select is a scalable, pre-configured, and validated solution with the rich features required for effective clinical trial management oversight and monitoring. Based on Calyx's 25+ years of expertise supporting diverse trials, it is perfectly tailored to meet the needs, timelines, and budgets of SMID organizations that don't require CTMS customization. Calyx CTMS Select is a scalable, pre-configured, and validated solution with the rich features required for effective clinical…

PMcardio Is The First Certified Solution To Outperform Doctors in Heart Attack…

LONDON, Nov.20, 2023(GLOBE NEWSWIRE) --Powerful Medical unveils a significant advancement in the fight against heart disease: the Queen of Hearts AI model within the PMcardio Platform, setting a new benchmark in heart attack diagnosis. This pioneering AI-powered clinical assistant is now the first certified solution proven to outperform doctors in detecting heart attacks. We live in a world where heart attacks remain the leading killer globally,with delayed or missed diagnoses...

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in…

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies Fortrea(Nasdaq: FTRE), a leading global contract research organization (CRO), today announced a partnership withMedidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, to useMedidata AI Intelligent Trialsto increase access to diverse patients in clinical trials conducted by Fortrea. Fortrea's use of...

Breathing Circuits Market Size to Surpass USD 524.0 million 2031s, at a CAGR…

Technology improves breathing circuits to enhance patient comfort, reduce infection rates, and increase efficiency. As integrated features have gained popularity in recent years, such as heat transfer, moisture transfer, and virus and bacteria filtration, they have become more prevalent. Technology improves breathing circuits to enhance patient comfort, reduce infection rates, and increase efficiency. As integrated features have gained popularity in recent years, such as heat transfer…

TSI Group Joins Halma Group, Unveiling New Avenues for Growth

"This is an exciting development for the TSI Group, supporting our ambitions to expand and develop globally," says Danny Fishman, President at the TSI Group. "We've engaged in extensive discussions with Halma, ensuring that they are the right home for our business. We are confident that this partnership will not only provide the stability we need but also offer the support to accelerate our growth." "This is an exciting development for the TSI Group, supporting our…

Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop…

With this agreement Chiesi will expand its product portfolio in its strategic respiratory field, aiming to further increase its impact in this area and contribute to developing treatments for severe respiratory diseases with high unmet medical needs. With this agreement Chiesi will expand its product portfolio in its strategic respiratory field, aiming to further increase its impact in this area and contribute to developing treatments for severe respiratory diseases with high unmet medical…

Nexstim Receives NBS System 6 Order from Hospital in United States

Press release, Helsinki, 20 November 2023 at 11 AM (EET)Nexstim Receives NBS System 6 Order from Hospital in United States Nexstim Plc (NXTMH:HEX) (“ Nexstim ” or “ Company ”) announces having received an NBS System 6 order from a hospital in Massachusetts, United States.Nexstim released the NBS 6 in the spring of 2023 and announced first order for the system on November 14. The NBS System 6 is a new generation system that makes Nexstim's established TMS technology even more intuitive...

Revolutionary Rick Simpson Oil Now Available in The UK

Rick Simpson, a true trailblazer in the field of cannabis-derived products, created RSO as a concentrated form of cannabis oil famed for its high THC content and potential therapeutic benefits. Despite its North American roots, acquiring high-quality RSO in the country's medical market was, for a long time, surprisingly challenging. This did not go unnoticed by wellness enthusiasts and medical patients alike, who longed for easier access to this groundbreaking product. Rick Simpson, a true...

Nearly half of UK adults feel unable to cope with stress, new Kalms study…

The research, commissioned by Kalms herbal remedies, considered financial struggles, hours of sleep achieved, daily commutes, quality time with close relationships and more. The research, commissioned byKalms herbal remedies, considered financial struggles, hours of sleep achieved, daily commutes, quality time with close relationships and more. Nationally, we're experiencing a sleep deprivation crisis with half (48%) of UK respondents saying stress prevents them from sleeping at night...

Altri Comunicati